PentaBind, shortlisted by Cancer Research UK as New Startup of the Year, is a cutting-edge AI aptamer drug discovery firm that recently saved 38 years of manual drug design time. It is now awaiting imminent results on the next generation of aptamer drugs that have huge applications in cancer and other diseases.

London, UK

Mile End, London, UK

Pentabind

Ambitious individuals leave places like Google, Goldman Sachs and Stanford to join EF. Why? Because starting a startup is the highest impact thing you can do with your life.    EF is the best place to find a co-founder, build a company and access the world's best investors. We've helped build over 80 technology companies, collectively worth over $1bn.
EF is backed by Reid Hoffman (founder of LinkedIn) and Greylock Partners, Mosaic Ventures, Founders Fund, Lakestar and some of the world's best entrepreneurs.
Read our manifesto here.

Entrepreneurs First

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Entrepreneur First Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Entrepreneur First network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Entrepreneur First company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Join aworld-changingstartup

Join a
world-changing
startup